Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 3Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Skin Neoplasms 1Sarcoma, Kaposi 1HIV Infections 1

Interventions

Magnetic Resonance Spectroscopy 13Ifosfamide 12Doxorubicin 12Blood Specimen Collection 12Radiotherapy 11Methotrexate 10fludarabine phosphate 9Surgical Procedures, Operative 9Radiosurgery 9Cyclophosphamide 9Surveys and Questionnaires 8Cyclosporine 8Proton Therapy 7Peripheral Blood Stem Cell Transplantation 7Busulfan 7Mycophenolic Acid 6Melphalan 6Whole-Body Irradiation 5Standard of Care 5Filgrastim 5Etoposide 5Early Intervention, Educational 5Carboplatin 5Biopsy 5Antilymphocyte Serum 5Vincristine 4Temozolomide 4Sunitinib 4Radiation Dose Hypofractionation 4Mesna 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Semaxinib × Sarcoma × Clear all
NCT00002226 2005-06-24

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase NA Completed
30 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡